Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38053
CAS Number:
155648-60-5
Minodronate monohydrate
Purity:
≥ 98% (HPLC)
Synonym(s):
1-Hydroxy-2-[imidazo[1,2-a]pyridin-3-yl]ethylidene-1,1-diphosphonic acid monohydrate, Minodronic acid monohydrate
Documents
$332.80 /25MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Minodronate monohydrate is a potent bisphosphonate compound primarily utilized in the treatment of osteoporosis and other bone-related disorders. This compound works by inhibiting osteoclast-mediated bone resorption, thereby enhancing bone density and strength. Its unique structure allows for effective targeting of bone tissue, making it particularly beneficial for patients at risk of fractures. Minodronate monohydrate is also being explored for its potential applications in various research settings, including studies on bone metabolism and the effects of bisphosphonates on cancer-related bone diseases.

In addition to its therapeutic uses, Minodronate monohydrate has shown promise in veterinary medicine for managing bone health in animals. Researchers and healthcare professionals appreciate its favorable pharmacokinetic profile, which supports its efficacy and safety in long-term use. With its ability to improve bone mineralization and reduce fracture risk, Minodronate monohydrate stands out as a valuable compound in both clinical and research applications.

Synonyms
1-Hydroxy-2-[imidazo[1,2-a]pyridin-3-yl]ethylidene-1,1-diphosphonic acid monohydrate, Minodronic acid monohydrate
CAS Number
155648-60-5
Purity
≥ 98% (HPLC)
Molecular Formula
C9H12N2O7P2·H2O
Molecular Weight
340.17
MDL Number
MFCD00890772
PubChem ID
23201029
Appearance
White to light yellow to light red powder to crystal
Conditions
Store at 2 - 8 °C
General Information
Synonyms
1-Hydroxy-2-[imidazo[1,2-a]pyridin-3-yl]ethylidene-1,1-diphosphonic acid monohydrate, Minodronic acid monohydrate
CAS Number
155648-60-5
Purity
≥ 98% (HPLC)
Molecular Formula
C9H12N2O7P2·H2O
Molecular Weight
340.17
MDL Number
MFCD00890772
PubChem ID
23201029
Appearance
White to light yellow to light red powder to crystal
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Minodronate monohydrate is widely utilized in research focused on:

  • Bone Health Treatments: This compound is primarily used in the treatment of osteoporosis, helping to strengthen bones and reduce the risk of fractures in postmenopausal women and individuals on long-term corticosteroid therapy.
  • Pharmaceutical Development: Researchers are exploring its efficacy in various formulations, enhancing drug delivery systems that target bone metabolism more effectively than traditional therapies.
  • Clinical Trials: Minodronate monohydrate is often involved in clinical studies assessing its long-term effects on bone density and overall skeletal health, providing valuable data for future treatments.
  • Veterinary Medicine: This compound is being investigated for its potential applications in treating bone-related conditions in animals, offering a new avenue for veterinary care.
  • Research on Bone Remodeling: Scientists utilize this chemical to study the mechanisms of bone remodeling, helping to uncover new insights into bone diseases and potential therapeutic targets.

Citations